Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1994-05-31
1995-08-29
Ivy, C. Warren
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
546 22, 546147, C07D21706, A61K 3147
Patent
active
054460514
ABSTRACT:
The present invention provides novel decahydroisoquinoline derivatives which are useful as excitatory amino acid antagonists. The invention also provides for methods of using these derivatives to treat various neurological disorders.
REFERENCES:
patent: 4902695 (1990-02-01), Ornstein
patent: 5284957 (1994-02-01), Huff
Boone David E.
Davis Zinna N.
Dodd Thomas J.
Eli Lilly and Company
Hay Martin A.
LandOfFree
Aryl-spaced decahydroisoquinoline-3-carboxylic acids as excitato does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Aryl-spaced decahydroisoquinoline-3-carboxylic acids as excitato, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Aryl-spaced decahydroisoquinoline-3-carboxylic acids as excitato will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1819631